Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su Pin Choo

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Cancers|December 11, 2019
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersDavid Tai, Su Pin Choo, Valerie Chew
Journal of Gastrointestinal Cancer|November 9, 2010
Hypoglycaemia in a 63-year-old female with a large, recurrent, metastatic gastrointestinal stromal tumour (GIST)Grace Tan, Melissa Teo, Su Pin Choo
International Journal of Hepatology|October 14, 2011
Targeted therapy in hepatocellular carcinomaClarinda W L Chua, Su Pin Choo
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Targeted therapies in the treatment of gastric cancerJoanne Ngeow, Iain Beehuat Tan, Su Pin Choo
Diseases (Basel, Switzerland)|September 26, 2017
Clinical Development of c-MET Inhibition in Hepatocellular CarcinomaJoycelyn J X Lee, Jack J Chan, Su Pin Choo
Onkologie|March 4, 2006
Breast lymphoma: favorable prognosis after treatment with standard combination chemotherapySu-Pin Choo, Soon-Thye Lim, Ee-Hwee Wong, et al.
Frontiers in Immunology|October 29, 2020
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and BeyondYun Hua Lee, David Tai, Connie Yip, et al.
Journal for Immunotherapy of Cancer|June 29, 2019
Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case seriesRayan Alsuwaigh, Joycelyn Lee, Gloria Chan, et al.
Contemporary Clinical Trials|April 18, 2013
The evolving landscape of therapeutic drug development for hepatocellular carcinomaDawn Qingqing Chong, Iain Beehuat Tan, Su-Pin Choo, et al.
Immunotherapy|February 8, 2019
Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case seriesDaniel Jiahao Wong, Joycelyn Lee, Su Pin Choo, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Cancers|December 11, 2019
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersDavid Tai, Su Pin Choo, Valerie Chew
Journal of Gastrointestinal Cancer|November 9, 2010
Hypoglycaemia in a 63-year-old female with a large, recurrent, metastatic gastrointestinal stromal tumour (GIST)Grace Tan, Melissa Teo, Su Pin Choo
International Journal of Hepatology|October 14, 2011
Targeted therapy in hepatocellular carcinomaClarinda W L Chua, Su Pin Choo
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Targeted therapies in the treatment of gastric cancerJoanne Ngeow, Iain Beehuat Tan, Su Pin Choo
Diseases (Basel, Switzerland)|September 26, 2017
Clinical Development of c-MET Inhibition in Hepatocellular CarcinomaJoycelyn J X Lee, Jack J Chan, Su Pin Choo
Onkologie|March 4, 2006
Breast lymphoma: favorable prognosis after treatment with standard combination chemotherapySu-Pin Choo, Soon-Thye Lim, Ee-Hwee Wong, et al.
Frontiers in Immunology|October 29, 2020
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and BeyondYun Hua Lee, David Tai, Connie Yip, et al.
Journal for Immunotherapy of Cancer|June 29, 2019
Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case seriesRayan Alsuwaigh, Joycelyn Lee, Gloria Chan, et al.
Contemporary Clinical Trials|April 18, 2013
The evolving landscape of therapeutic drug development for hepatocellular carcinomaDawn Qingqing Chong, Iain Beehuat Tan, Su-Pin Choo, et al.
Immunotherapy|February 8, 2019
Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case seriesDaniel Jiahao Wong, Joycelyn Lee, Su Pin Choo, et al.
Pageof 10